Table 1 Description of the total study population
| Â | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 |
|---|---|---|---|---|---|---|---|
Subjects per year, n | 3 309 447 | 3 444 950 | 3 601 468 | 4 506 287 | 4 631 043 | 4 705 226 | 4 797 459 |
Women, % | 52.5 | 52.6 | 52.6 | 52.7 | 52.7 | 52.7 | 52.7 |
Subjects per age band, % | |||||||
 18-44 | 44.8 | 44.0 | 43.1 | 41.6 | 40.8 | 39.8 | 38.9 |
 45-64 | 33.0 | 33.0 | 33.2 | 33.3 | 33.3 | 33.3 | 33.3 |
 65-84 | 20.7 | 21.1 | 21.3 | 22.0 | 22.4 | 22.9 | 23.2 |
 85+ | 1.6 | 2.0 | 2.4 | 3.1 | 3.6 | 4.0 | 4.5 |
Antidiabetic usersa (crude), % | 5.2 | 5.5 | 5.8 | 6.2 | 6.2 | 6.4 | 6.5 |
Antidiabetic usersa (age-sex standardized), % | 5.6 | 5.8 | 6.1 | 6.3 | 6.2 | 6.2 | 6.2 |